A phase II trial of the effect of perindopril on hand–foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC

por Melosky, Barbara L., Lim, Howard John, Davies, Janine Marie, Gill, Sharlene, Kollmannsberger, Christian K., Ho, Maria Yi, Vandt, Solomon A., Renouf, Daniel John
Publicado 2018